-
1
-
-
79952783821
-
-
Table1: Annual estimates of the population by sex and five-year age groups for the United States: April 1, to July 1, 2007, NC-EST2007-01. May 2008
-
Population Division US Census Bureau. Table1: Annual estimates of the population by sex and five-year age groups for the United States: April 1, 2000 to July 1, 2007. NC-EST2007-01. May 2008
-
(2000)
Population Division US Census Bureau
-
-
-
2
-
-
0032845731
-
A randomized comparison of continuous combined transdermal delivery of estradiol-norethindrone acetate and estradiol alone for menopause
-
DOI 10.1016/S0029-7844(99)00359-2, PII S0029784499003592
-
Archer DF, Furst K, Tipping D, Dain MP, Vandepol C. A randomized comparison of continuous combined transdermal delivery of estradiol- norethindrone acetate and estradiol alone for menopause. CombiPatch Study Group. Obstet Gynecol 1999; 94:498-503 (Pubitemid 29460929)
-
(1999)
Obstetrics and Gynecology
, vol.94
, Issue.4
, pp. 498-503
-
-
Archer, D.F.1
Furst, K.2
Tipping, D.3
Dain, M.-P.4
Vandepol, C.5
-
3
-
-
0020335470
-
Pathophysical mechanisms of estrogen effect on bone metabolism. Dose-respone relationsips in early postmenopausal women
-
Christiansen C, Christensen MS, Larsen NE, Transbol IB. Pathophysiological mechanisms of estrogen effect on bone metabolism. Dose-response relationships in early postmenopausal women. J Clin Endocrinol Metab 1982;55:1124-30 (Pubitemid 13204254)
-
(1982)
Journal of Clinical Endocrinology and Metabolism
, vol.55
, Issue.6
, pp. 1124-1130
-
-
Christiansen, C.1
Christensen, M.S.2
Larsen, N.E.3
Transbol, I.4
-
4
-
-
0037125379
-
Risks and benefits of estrogen plus progestin in healthy postmenopausal women
-
Women's Health Initiative
-
Women's Health Initiative. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002;288: 321-33
-
(2002)
JAMA
, vol.288
, pp. 321-333
-
-
-
5
-
-
0042018741
-
Breast cancer and hormone-replacement therapy in the Million Women Study
-
DOI 10.1016/S0140-6736(03)14065-2
-
Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003;362:419-27 (Pubitemid 36999703)
-
(2003)
Lancet
, vol.362
, Issue.9382
, pp. 419-427
-
-
Beral, V.1
-
6
-
-
0037830132
-
Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal Women: The Women's Health Initiative Randomized Trial
-
DOI 10.1001/jama.289.24.3243
-
Chlebowski RT, Hendrix SL, Langer RD, et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: The Women's Health Initiative randomized trial. JAMA 2003;289:3243-53 (Pubitemid 37430077)
-
(2003)
Journal of the American Medical Association
, vol.289
, Issue.24
, pp. 3243-3253
-
-
Chlebowski, R.T.1
Hendrix, S.L.2
Langer, R.D.3
Stefanick, M.L.4
Gass, M.5
Lane, D.6
Rodabough, R.J.7
Gilligan, M.A.8
Cyr, M.G.9
Thomson, C.A.10
Khandekar, J.11
Petrovitch, H.12
McTiernan, A.13
-
7
-
-
0030843969
-
Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer
-
Collaborative Group on Hormonal Factors in Breast Cancer
-
Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997;350:1047-59
-
(1997)
Lancet
, vol.350
, pp. 1047-1059
-
-
-
8
-
-
39449118229
-
A common 8q24 variant and the risk of colon cancer: A population-based case-control study
-
DOI 10.1158/1055-9965.EPI-07-0713
-
Li L, Plummer SJ, Thompson CL, et al. A common 8q24 variant and the risk of colon cancer: A population-based case-control study. Cancer Epidemiol Biomarkers Prev 2008;17:339-42 (Pubitemid 351272784)
-
(2008)
Cancer Epidemiology Biomarkers and Prevention
, vol.17
, Issue.2
, pp. 339-342
-
-
Li, L.1
Plummer, S.J.2
Thompson, C.L.3
Merkulova, A.4
Acheson, L.S.5
Tucker, T.C.6
Casey, G.7
-
9
-
-
33845383231
-
Breast cancer risk in postmenopausal women using estrogen-only therapy
-
DOI 10.1097/01.AOG.0000241091.86268.6e, PII 0000625020061200000004
-
Lyytinen H, Pukkala E, Ylikorkala O. Breast cancer risk in postmenopausal women using estrogen-only therapy. Obstet Gynecol 2006;108:1354-60 (Pubitemid 44901007)
-
(2006)
Obstetrics and Gynecology
, vol.108
, Issue.6
, pp. 1354-1360
-
-
Lyytinen, H.1
Pukkala, E.2
Ylikorkala, O.3
-
10
-
-
0037125454
-
Menopausal hormone replacement therapy and risk of ovarian cancer
-
Lacey JV, Mink PJ, Lubin JH, et al. Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA 2002;288: 334-41 (Pubitemid 34761612)
-
(2002)
Journal of the American Medical Association
, vol.288
, Issue.3
, pp. 334-341
-
-
Lacey Jr., J.V.1
Mink, P.J.2
Lubin, J.H.3
Sherman, M.E.4
Troisi, R.5
Hartge, P.6
Schatzkin, A.7
Schairer, C.8
-
11
-
-
0037125379
-
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the women's health initiative randomized controlled trial
-
Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33 (Pubitemid 34761611)
-
(2002)
Journal of the American Medical Association
, vol.288
, Issue.3
, pp. 321-333
-
-
Rossouw, J.E.1
Anderson, G.L.2
Prentice, R.L.3
LaCroix, A.Z.4
Kooperberg, C.5
Stefanick, M.L.6
Jackson, R.D.7
Beresford, S.A.A.8
Howard, B.V.9
Johnson, K.C.10
Kotchen, J.M.11
Ockene, J.12
-
12
-
-
18144421167
-
Endometrial cancer and hormonereplacement therapy in the Million Women Study
-
Beral V, Bull D, Reeves G. Endometrial cancer and hormonereplacement therapy in the Million Women Study. Lancet 2005; 365:1543-51
-
(2005)
Lancet
, vol.365
, pp. 1543-1551
-
-
Beral, V.1
Bull, D.2
Reeves, G.3
-
13
-
-
0018891803
-
Use of the progestogen challenge test to reduce the risk of endometrial cancer
-
Gambrell RD Jr, Massey FM, Castaneda TA, et al. Use of the progestogen challenge test to reduce the risk of endometrial cancer. Obstet Gynecol 1980;55:732-8 (Pubitemid 10068686)
-
(1980)
Obstetrics and Gynecology
, vol.55
, Issue.6
, pp. 732-738
-
-
Gambrell, R.D.1
Massey, F.M.2
Castaneda, T.A.3
-
15
-
-
77953643561
-
DHEA after menopause - sole source of sex steroids and potential sex steroid deficiency treatment
-
Labrie F. DHEA after menopause - sole source of sex steroids and potential sex steroid deficiency treatment. Menopause Management 2010;19:14-24
-
(2010)
Menopause Management
, vol.19
, pp. 14-24
-
-
Labrie, F.1
-
17
-
-
34447623585
-
Drug Insight: Breast cancer prevention and tissue-targeted hormone replacement therapy
-
DOI 10.1038/ncpendmet0559, PII NCPENDMET0559
-
Labrie F. Drug Insight: Breast cancer prevention and tissuetargeted hormone replacement therapy. Nature Clinical Practice, Endocrinology & Metabolism 2007;3:584-93 (Pubitemid 47094559)
-
(2007)
Nature Clinical Practice Endocrinology and Metabolism
, vol.3
, Issue.8
, pp. 584-593
-
-
Labrie, F.1
-
18
-
-
73349115224
-
Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy
-
Labrie F, Archer D, Bouchard C, et al. Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy. Menopause 2009;16:907-22
-
(2009)
Menopause
, vol.16
, pp. 907-922
-
-
Labrie, F.1
Archer, D.2
Bouchard, C.3
-
19
-
-
72249101980
-
Effect on intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women
-
Labrie F, Archer D, Bouchard C, et al. Effect on intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women. Menopause 2009;16:923-31
-
(2009)
Menopause
, vol.16
, pp. 923-931
-
-
Labrie, F.1
Archer, D.2
Bouchard, C.3
-
20
-
-
73349105263
-
Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration
-
Labrie F, Archer D, Bouchard C, et al. Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration. Menopause 2009;16:897-906
-
(2009)
Menopause
, vol.16
, pp. 897-906
-
-
Labrie, F.1
Archer, D.2
Bouchard, C.3
-
21
-
-
0014109952
-
The maturation value
-
Meisels A. The maturation value. Acta Cytol 1967;11:249
-
(1967)
Acta Cytol
, vol.11
, pp. 249
-
-
Meisels, A.1
-
22
-
-
0027454291
-
Industrial developments in automated cytology as submitted by their developers
-
Wied GL. Industrial developments in automated cytology as submitted by their developers. Anal Quant Cytol Histol 1993;15:358-70 (Pubitemid 23311389)
-
(1993)
Analytical and Quantitative Cytology and Histology
, vol.15
, Issue.5
, pp. 358-370
-
-
Wied, G.L.1
-
23
-
-
49449119071
-
Effect of intravaginal DHEA on serum DHEA and eleven of its metabolites in postmenopausal women
-
Labrie F, Cusan L, Gomez JL, et al. Effect of intravaginal DHEA on serum DHEA and eleven of its metabolites in postmenopausal women. J Steroid Biochem Mol Biol 2008;111:178-94
-
(2008)
J Steroid Biochem Mol Biol
, vol.111
, pp. 178-194
-
-
Labrie, F.1
Cusan, L.2
Gomez, J.L.3
-
24
-
-
55349137697
-
Corrigendum to: Effect of intravaginal DHEA on serum DHEA and eleven of its metabolites in postmenopausal women
-
Labrie F, Cusan L, Gomez JL, et al. Corrigendum to: Effect of intravaginal DHEA on serum DHEA and eleven of its metabolites in postmenopausal women. J Steroid Biochem Mol Biol 2008; 112:169
-
(2008)
J Steroid Biochem Mol Biol
, vol.112
, pp. 169
-
-
Labrie, F.1
Cusan, L.2
Gomez, J.L.3
-
25
-
-
0034658676
-
Diagnosis and treatment of atrophic vaginitis
-
Bachmann GA, Nevadunsky NS. Diagnosis and treatment of atrophic vaginitis. Am Fam Physician 2000;61:3090-6 (Pubitemid 30347020)
-
(2000)
American Family Physician
, vol.61
, Issue.10
, pp. 3090-3096
-
-
Bachmann, G.A.1
Nevadunsky, N.S.2
-
27
-
-
37549023420
-
Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: A randomized controlled trial
-
Bachmann G, Lobo RA, Gut R, Nachtigall L, Notelovitz M. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: A randomized controlled trial. Obstet Gynecol 2008;111:67-76
-
(2008)
Obstet Gynecol
, vol.111
, pp. 67-76
-
-
Bachmann, G.1
Lobo, R.A.2
Gut, R.3
Nachtigall, L.4
Notelovitz, M.5
-
28
-
-
58149280795
-
Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tablet
-
Simon J, Nachtigall L, Gut R, et al. Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tablet. Obstet Gynecol 2008;112:1053-60
-
(2008)
Obstet Gynecol
, vol.112
, pp. 1053-1060
-
-
Simon, J.1
Nachtigall, L.2
Gut, R.3
-
29
-
-
77951782692
-
Minimized estradiol absorption with ultra-low-dose 10 mg 17b-estradiol vaginal tablets
-
Eugster-Hausmann M, Waitzinger J, Lehnick D. Minimized estradiol absorption with ultra-low-dose 10 mg 17b-estradiol vaginal tablets. Climacteric 2010;13:219-27
-
(2010)
Climacteric
, vol.13
, pp. 219-227
-
-
Eugster-Hausmann, M.1
Waitzinger, J.2
Lehnick, D.3
-
30
-
-
77952270259
-
Ospemifene effectively treats vulvovaginal atrophy in postmenopausal women: Results from a pivotal phase 3 study
-
Ospemifene Study Group
-
Bachmann GA, Komi JO, Ospemifene Study Group. Ospemifene effectively treats vulvovaginal atrophy in postmenopausal women: Results from a pivotal phase 3 study. Menopause 2010;17:480-6
-
(2010)
Menopause
, vol.17
, pp. 480-486
-
-
Bachmann, G.A.1
Komi, J.O.2
-
31
-
-
84987844143
-
Effect of toremifene and ospemifene, compared to acolbifene, on estrogensensitive parameters in rat and human uterine tissues
-
Labrie F, Martel C, Gauthier S, Pelletier G, Sancéau JY. Effect of toremifene and ospemifene, compared to acolbifene, on estrogensensitive parameters in rat and human uterine tissues. Horm Mol Biol Clin Invest 2010;1:139-46
-
(2010)
Horm Mol Biol Clin Invest
, vol.1
, pp. 139-146
-
-
Labrie, F.1
Martel, C.2
Gauthier, S.3
Pelletier, G.4
Sancéau, J.Y.5
-
32
-
-
17744368482
-
Selective estrogenic effects of a novel triphenylethylene compound, FC1271a, on bone, cholesterol level, and reproductive tissues in intact and ovariectomized rats
-
DOI 10.1210/en.141.2.809
-
Qu Q, Zheng H, Dahllund J, et al. Selective estrogenic effects of a novel triphenylethylene compound, FC1271a, on bone, cholesterol level, and reproductive tissues in intact and ovariectomized rats. Endocrinology 2000;141:809-20 (Pubitemid 32250507)
-
(2000)
Endocrinology
, vol.141
, Issue.2
, pp. 809-820
-
-
Qu, Q.1
Zheng, H.2
Dahllund, J.3
Laine, A.4
Cockcroft, N.5
Peng, Z.6
Koskinen, M.7
Hemminki, K.8
Kangas, L.9
Vaananen, K.10
Harkonen, P.11
-
33
-
-
69649108864
-
The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of the North American menopause society
-
NAMS
-
NAMS. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 Position Statement of the North American Menopause Society. Menopause 2007;14: 357-69
-
(2007)
Menopause
, vol.14
, pp. 357-369
-
-
-
35
-
-
0030842630
-
Postmenopausal vaginal atrophy and atrophic vaginitis
-
DOI 10.1097/00000441-199710000-00004
-
Pandit L, Ouslander JG. Postmenopausal vaginal atrophy and atrophic vaginitis. Am J Med Sci 1997;314:228-31 (Pubitemid 27435448)
-
(1997)
American Journal of the Medical Sciences
, vol.314
, Issue.4
, pp. 228-231
-
-
Pandit, L.1
Ouslander, J.G.2
-
37
-
-
33646793000
-
Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women
-
DOI 10.1016/j.jsbmb.2006.02.004, PII S0960076006000598
-
Labrie F, Bélanger A, Bélanger P, et al. Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women. J Steroid Biochem Mol Biol 2006;99:182-8 (Pubitemid 43766081)
-
(2006)
Journal of Steroid Biochemistry and Molecular Biology
, vol.99
, Issue.4-5
, pp. 182-188
-
-
Labrie, F.1
Belanger, A.2
Belanger, P.3
Berube, R.4
Martel, C.5
Cusan, L.6
Gomez, J.7
Candas, B.8
Castiel, I.9
Chaussade, V.10
Deloche, C.11
Leclaire, J.12
-
38
-
-
59849125252
-
Comparable amounts of sex steroids are made outside the gonads in men and women: Strong lesson for hormone therapy of prostate and breast cancer
-
Labrie F, Cusan L, Gomez JL, et al. Comparable amounts of sex steroids are made outside the gonads in men and women: Strong lesson for hormone therapy of prostate and breast cancer. J Steroid Biochem Mol Biol 2009;113:52-6
-
(2009)
J Steroid Biochem Mol Biol
, vol.113
, pp. 52-56
-
-
Labrie, F.1
Cusan, L.2
Gomez, J.L.3
-
39
-
-
44649190349
-
Changes in serum DHEA and eleven of its metabolites during 12-month percutaneous administration of DHEA
-
Labrie F, Cusan L, Gomez JL, et al. Changes in serum DHEA and eleven of its metabolites during 12-month percutaneous administration of DHEA. J Steroid Biochem Mol Biol 2008;110:1-9
-
(2008)
J Steroid Biochem Mol Biol
, vol.110
, pp. 1-9
-
-
Labrie, F.1
Cusan, L.2
Gomez, J.L.3
-
40
-
-
32044435429
-
Hormone therapy and coronary heart disease: The role of time since menopause and age at hormone initiation
-
DOI 10.1089/jwh.2006.15.35
-
Grodstein F, Manson JE, Stampfer MJ. Hormone therapy and coronary heart disease: The role of time since menopause and age at hormone initiation. JWomens Health (Larchmt) 2006;15:35-44 (Pubitemid 43192860)
-
(2006)
Journal of Women's Health
, vol.15
, Issue.1
, pp. 35-44
-
-
Grodstein, F.1
Manson, J.E.2
Stampfer, M.J.3
-
41
-
-
32644436832
-
Conjugated equine estrogens and coronary heart disease: The women's health initiative
-
DOI 10.1001/archinte.166.3.357
-
Hsia J, Langer RD, Manson JE, et al. Conjugated equine estrogens and coronary heart disease: The Women's Health Initiative. Arch Intern Med 2006;166:357-65 (Pubitemid 43244325)
-
(2006)
Archives of Internal Medicine
, vol.166
, Issue.3
, pp. 357-365
-
-
Hsia, J.1
Langer, R.D.2
Manson, J.E.3
Kuller, L.4
Johnson, K.C.5
Hendrix, S.L.6
Pettinger, M.7
Heckbert, S.R.8
Greep, N.9
Crawford, S.10
Eaton, C.B.11
Kostis, J.B.12
Caralis, P.13
Prentice, R.14
-
42
-
-
34547181486
-
The heart of the WHI study: Time for hormone therapy policies to be revised
-
DOI 10.1080/13697130701543783, PII 780574399
-
Pines A, Sturdee DW, MacLennan AH, et al. The heart of the WHI study: Time for hormone therapy policies to be revised. Climacteric 2007;10:267-9 (Pubitemid 47123948)
-
(2007)
Climacteric
, vol.10
, Issue.4
, pp. 267-269
-
-
Pines, A.1
Sturdee, D.W.2
MacLennan, A.H.3
Schneider, H.P.G.4
Burger, H.5
Fenton, A.6
-
43
-
-
0037012342
-
Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women
-
Riman T, Dickman PW, Nilsson S, et al. Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women. J Natl Cancer Inst 2002;94:497-504 (Pubitemid 34411288)
-
(2002)
Journal of the National Cancer Institute
, vol.94
, Issue.7
, pp. 497-504
-
-
Riman, T.1
Dickman, P.W.2
Nilsson, S.3
Correia, N.4
Nordlinder, H.5
Magnusson, C.M.6
Weiderpass, E.7
Persson, I.R.8
-
44
-
-
78651408128
-
The menopause brain effect: Can hormone therapy help?
-
Ruttimann J. The menopause brain effect: Can hormone therapy help? Endocrine News 2008;15-16
-
(2008)
Endocrine News
, pp. 15-16
-
-
Ruttimann, J.1
-
45
-
-
84965028377
-
Dehydroepiandrosterone and androsterone levels in human plasma. Effect of age and sex: Day-to-day and diurnal variations
-
Migeon CJ, Keller AR, Lawrence B, Shepart II TH. Dehydroepiandrosterone and androsterone levels in human plasma. Effect of age and sex: Day-to-day and diurnal variations. J Clin Endocrinol Metab 1957;17:1051-62
-
(1957)
J Clin Endocrinol Metab
, vol.17
, pp. 1051-1062
-
-
Migeon, C.J.1
Keller, A.R.2
Lawrence, B.3
Shepart II, T.H.4
-
46
-
-
0020384812
-
Adrenocortical function in old age: Response to acute adrenocorticotropin stimulation
-
Vermeulen A, Deslypene JP, Schelfhout W, Verdonck L, Rubens R. Adrenocortical function in old age: Response to acute adrenocorticotropin stimulation. J Clin Endocrinol Metab 1982;54:187-91 (Pubitemid 13242156)
-
(1982)
Journal of Clinical Endocrinology and Metabolism
, vol.54
, Issue.1
, pp. 187-191
-
-
Vermeulen, A.1
Deslypere, J.P.2
Schelfhout, W.3
-
47
-
-
77956639804
-
DHEA, important source of sex steroids in men and even more in women
-
In Martini L, Chrousos GP, Labrie F, Pacak K, Pfaff D, eds., New York: Elsevier
-
Labrie F. DHEA, important source of sex steroids in men and even more in women. In Martini L, Chrousos GP, Labrie F, Pacak K, Pfaff D, eds. Neuroendocrinology, The Normal Neuroendocrine System, Progress in Brain Research. New York: Elsevier, 2010:97-148
-
(2010)
Neuroendocrinology, The Normal Neuroendocrine System, Progress in Brain Research
, pp. 97-148
-
-
Labrie, F.1
-
48
-
-
0030883203
-
Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women
-
DOI 10.1210/jc.82.10.3498
-
Labrie F, Diamond P, Cusan L, et al. Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women. J Clin Endocrinol Metab 1997;82:3498-505 (Pubitemid 27419111)
-
(1997)
Journal of Clinical Endocrinology and Metabolism
, vol.82
, Issue.10
, pp. 3498-3505
-
-
Labrie, F.1
Diamond, P.2
Cusan, L.3
Gomez, J.-L.4
Belanger, A.5
Candas, B.6
-
49
-
-
45849111454
-
Androgen therapy for loss of desire in women: is the benefit worth the breast cancer risk?
-
DOI 10.1016/j.fertnstert.2007.05.057, PII S0015028207012290
-
Schover LR. Androgen therapy for loss of desire in women: Is the benefit worth the breast cancer risk? Fertil Steril 2008;90:129-40 (Pubitemid 351888358)
-
(2008)
Fertility and Sterility
, vol.90
, Issue.1
, pp. 129-140
-
-
Schover, L.R.1
-
50
-
-
34047270712
-
Associations between testosterone secretion and sexual activity in women
-
DOI 10.1016/j.yhbeh.2007.01.003, PII S0018506X07000049
-
van Anders SM, Hamilton LD, Schmidt N, Watson NV. Associations between testosterone secretion and sexual activity in women. Horm Behav 2007;51:477-82 (Pubitemid 46550424)
-
(2007)
Hormones and Behavior
, vol.51
, Issue.4
, pp. 477-482
-
-
Van Anders, S.M.1
Hamilton, L.D.2
Schmidt, N.3
Watson, N.V.4
-
51
-
-
15744384106
-
Waist-to-hip ratio is positively associated with bioavailable testosterone but negatively associated with sexual desire in healthy premenopausal women
-
DOI 10.1097/01.psy.0000151747.22904.d7
-
van Anders SM, Hampson E. Waist-to-hip ratio is positively associated with bioavailable testosterone but negatively associated with sexual desire in healthy premenopausal women. Psychosom Med 2005;67:246-50 (Pubitemid 40410960)
-
(2005)
Psychosomatic Medicine
, vol.67
, Issue.2
, pp. 246-250
-
-
Van Anders, S.M.1
Hampson, E.2
|